Now Reading: Latham Advises GT Medical Technologies in US$35 Million Loan Facility
1
-
01
Latham Advises GT Medical Technologies in US$35 Million Loan Facility
Emerging Companies & Growth team represented the medical device company in the financing.
GT Medical Technologies, Inc. (GT MedTech), a medical device company with a corporate purpose of improving the lives of patients with brain tumors, has announced that it has secured a US$35 million venture loan facility, of which US$15 million has been initially funded from Horizon Technology Finance Corporation, an affiliate of Monroe Capital.
Latham & Watkins LLP represented GT MedTech in the loan facility with a finance team led by Bay Area partner Dan Van Fleet, with associates Hyunji Lee and Ian Drazen. Advice was also provided on corporate matters by Bay Area partners Benjamin Potter and Luke Bergstrom, with associates Omar Ammash, Erica Kucharski, and Amarantha Gomez; on environmental matters by Los Angeles/Houston partner Joshua Marnitz; on sanctions matters by Washington, D.C. counsel Andrew Galdes, with associate Jessie Michelin; and on tax matters by Los Angeles partner Eric Cho
